Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells. (2014)

First Author: Filipovic A
Attributed to:  Molecular Therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s10549-014-3119-z

PubMed Identifier: 25248409

Publication URI: http://europepmc.org/abstract/MED/25248409

Type: Journal Article/Review

Volume: 148

Parent Publication: Breast cancer research and treatment

Issue: 2

ISSN: 0167-6806